3D Cell Culture Market Size to Hit USD 6.8 Billion by 2030

According to Nova one advisor, the global 3D Cell Culture market size is expected to hit around USD 6.8 billion by 2030 from valued at USD 2.9 billion in 2021 and growing at a CAGR of 11.40% from 2022 to 2030

Request Free Sample of This Report@ https://www.novaoneadvisor.com/report/sample/7328

Key Takeaways:

• The scaffold-based technology segment is anticipated to register a lucrative year-on-year growth owing to rising demand for 3D model-based research coupled with an increased incidence of chronic diseases
• Moreover, the introduction of novel tools and techniques is anticipated to boost revenue generation in the scaffold-based technology segment
• Furthermore, companies, such as Tecan and Sigma-Aldrich, offer scaffold-based 3D solutions; which are readily adopted by the end users
• Cancer was the largest application segment of the market in 2021. This is because 3D cultures efficiently replicate the associated influences and complexity of in vivo tumor microenvironment including the impact of extracellular matrix and cell-to-cell contact
• Cells in 3-dimensional cultures help in the analysis of behavior and properties of the tumor, protein distribution, gene expression, and monitor response to anticancer therapies
• Potential scientific and clinical impacts of the 3D-cultivation approach for embryonic, adult, and cancer stem cells are estimated to boost the growth of the stem cell research segment
• Biotechnology and pharmaceutical organizations accounted for the largest share in 2021 owing to a rise in the adoption of 3D cell culture techniques in tissue engineering and drug discovery
• Combination of 3D cell culture techniques with Human-induced Pluripotent Stem Cells (HiPSCs) has been successfully used for the development and discovery of drugs for liver diseases
• North America led the market in 2021 owing to extensive usage of 3D cell culture models for medical research purposes
• In April 2021, a team of researchers from the University of Pittsburgh used Multicellular Tumor Spheroids (MCTSs) to assess drug responses in drug screening studies for oncology
• Asia Pacific is expected to register the fastest CAGR from 2022 to 2030 due to rising investments by North American and European companies in APAC regional market
• The key market players focus on geographical expansions, partnerships, collaborations, acquisitions, and novel product launches to reinforce their market presence
• For instance, in December 2020, Curiteva, Inc. acquired FossiLabs, LLC. The latter has developed a process to fabricate scaffolding structures that promote osseointegration

Ask here for more customization study@ https://www.novaoneadvisor.com/report/customization/7328

The development of 3D optimized assays, kits, and protocols coupled with the evolution of assay techniques is anticipated to drive the three-dimensional cell culture market.

As 3-dimensional cultures have the capacity to closely mimic a typical morphology and microarchitecture of organs, these are continuously developed for the studies that require in vivo model systems to analyze the effect of a foreign drug over body tissues and organs. This, coupled with the availability of various choices in terms of material and structure of the scaffold for different in vitro applications, is anticipated to support revenue generation for scaffolds.

Recent researches have explored the use of a diverse range of scaffolds including graphene scaffolds, nanofibers, freeze-casting, natural marine collagen, and others. In addition, the application of lab-on-a-chip techniques in several assay types-proliferation, viability, stimulation, transport, patch clamping, high content screening, and metabolic activity-leads to a rise in demand for projects with advanced and efficient solutions.

Report Scope of the 3D Cell Culture Market

Regional Insights

North America led the global market in 2021 and accounted for the highest revenue share of over 43%. The region will retain its leading position throughout the forecast period on account of the availability of private and government funding for the development of advanced 3D cell culture models, high healthcare spending, and the presence of a large number of universities and research organizations investigating various stem cell-based approaches. In December 2020, researchers from Mayo Clinic and Terasaki Institute, U.S., developed visible hydrogels that can be used for the monitoring and control of hemorrhage.

The “2021: A New Vision” initiative by the U.S. Department of Health and Human Services recognizes regenerative medicine at the forefront of healthcare. The transformative impact of the use of regenerative medicine at clinical stages is of utmost importance in translational progress and technological innovation. However, Asia Pacific is estimated to be the fastest-growing regional market from 2021 to 2028 owing to increasing investments by various international companies in the emerging economies of this region.

 Some of the prominent players in the 3D Cell Culture Market include:

• Merck KGaA
• Thermo Fisher Scientific, Inc.
• PromoCell GmbH
• Greiner Bio One International GmbH
• Corning, Inc.
• 3D Biomatrix
• Lonza
• Avantor Performance Materials, LLC
• Tecan Trading AG
• 3D Biotek LLC
• Global Cell Solutions, Inc.
• InSphero

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global 3D Cell Culture market

• Technology
  • Scaffold-based
    • Hydrogels
    • Polymeric Scaffolds
    • Micro-patterned Surface Microplates
    • Nanofiber-based Scaffolds
  • Scaffold-free
    • Hanging Drop Microplates
    • Microfluidic 3D Cell Culture
    • Spheroid Microplates with ULA coating
    • Magnetic Levitation & 3D Bioprinting
  • Bioreactors
• Application
  • Cancer
  • Tissue Engineering & Immunohistochemistry
  • Drug Development
  • Stem Cell Research
  • Others
• End-use
  • Biotechnology and Pharmaceutical Industries
  • Research Laboratories and Institutes
  • Hospitals and Diagnostic Centers
  • Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Full Report is Ready | For Purchase Inquiry@ https://www.novaoneadvisor.com/report/checkout/7328

You can place an order or ask any questions, please feel free to sales@novaoneadvisor.com| +1 9197 992 333

Blog: https://www.novaoneadvisor.com/

Blog: https://www.visionresearchreports.com/

Blog: https://qyresearchmedical.com/